Page last updated: 2024-11-06

prednisolone and 2019 Novel Coronavirus Disease

prednisolone has been researched along with 2019 Novel Coronavirus Disease in 103 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Research Excerpts

ExcerptRelevanceReference
"Acquired haemophilia A (AHA) is a rare bleeding disorder, characterised by the presence of autoantibodies to clotting factor VIII (FVIII)."5.72Acquired Hemophilia A following Pfizer-BioNTech SARS CoV-2 mRNA vaccine, successfully treated with prednisolone and rituximab. ( Gilbar, PJ; Mangos, HM; Murali, A; Wong, P, 2022)
"High cumulative prednisolone dose, baseline neutropenia, hypoalbuminemia, multiple cavities on CT chest, leukopenia, lymphopenia and raised inflammatory markers were associated with poor prognosis in severe COVID-19 patients with cavitating fungal pneumonia."4.12Clinical Profile, Risk Factors, and Therapeutic Outcome of Cavitating Fungal Pneumonia Coinfection in COVID-19 Patients: A Retrospective Analysis. ( Banerjee, S; Dua, R; Kumar, A; Mishra, M; Saini, LK; Sharma, P; Sindhwani, G, 2022)
" The common symptoms, complications, comorbidities, and medications were fever, pneumonia, hypertension, and prednisolone, respectively."4.12Analysis of potential risk factors associated with COVID-19 and hospitalization. ( Alamri, AS; Aldhwayan, NI; Alharbi, AA; Alharbi, AM; Alharbi, NS; Alhomrani, M; Almohaimeed, AT; Almushayti, BK; Alsanie, WF; Asdaq, SMB; Halim Mohamed, AA; Rabbani, SI, 2022)
" With only few case studies published on SARS-CoV-2 infection in patients with rheumatic diseases, we report a 25-year-old male who developed moderate coronavirus disease 2019 (COVID-19) with fever, mild dyspnea, and no major complications despite having received high-dose prednisolone, cyclophosphamide, and rituximab for the treatment of highly active, life-threatening eosinophilic granulomatosis with polyangiitis (EGPA)."3.96COVID-19 in a Severely Immunosuppressed Patient With Life-Threatening Eosinophilic Granulomatosis With Polyangiitis. ( Craig-Mueller, N; Hengel, H; Huzly, D; Kern, WV; Panning, M; Schramm, MA; Thiel, J; Venhoff, N; Voll, RE; Wagner, D, 2020)
" A 40-year-old man with a history of rheumatoid arthritis treated with prednisolone, Disease-Modifying Anti-Rheumatic Drugs (DMARDs), and biologic agents was admitted with chief complaints of fever, chills, malaise, myalgia, and dyspnea."3.96COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with? ( Ahmadinejad, Z; Assari, R; Ayoobi Yazdi, N; Javanshayani, P; Khalili Afousi, H; Mazloomi, SH; Ziaee, V, 2020)
" A phase II selection design will be used to determine hdroxychloroquine's efficacy, using prednisolone dosage and Birmingham Vasculitis Activity Score as a measure of disease activity."3.30The HAVEN study-hydroxychloroquine in ANCA vasculitis evaluation-a multicentre, randomised, double-blind, placebo-controlled trial: study protocol and statistical analysis plan. ( Arnold, L; Beckley-Hoelscher, N; Cape, A; Casian, A; D'Cruz, D; Douiri, A; Galloway, J; Jayne, D; John, S; Kim, S; Learoyd, AE; Luqmani, R; Morton, N; Nel, L; Reid, F; Sangle, S; Shivapatham, D, 2023)
"Management of drug-drug interactions (DDIs) for ensitrelvir, a novel 3-chymotrypsin-like protease inhibitor of SARS-CoV-2 infection is crucial."3.30Evaluation of the Drug-Drug Interaction Potential of Ensitrelvir Fumaric Acid with Cytochrome P450 3A Substrates in Healthy Japanese Adults. ( Fukuhara, T; Kubota, R; Kuwata, A; Matsuo, Y; Matsuzaki, T; Shimizu, R; Sonoyama, T, 2023)
"Prednisolone has been suggested as a treatment for olfactory disorders after COVID-19, but evidence is scarce."3.11Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial. ( Blijleven, EE; Boek, WM; Boesveldt, S; Kamalski, DMA; Schepens, EJA; Stegeman, I; Stokroos, RJ, 2022)
"These patients have a very high coronavirus disease 2019 (COVID-19)-related mortality, whereas their response to COVID-19 vaccination is impaired."3.11Enhanced Humoral Immune Response After COVID-19 Vaccination in Elderly Kidney Transplant Recipients on Everolimus Versus Mycophenolate Mofetil-containing Immunosuppressive Regimens. ( Berger, SP; de Boer, SE; Kroesen, BJ; Sanders, JF; van Baarle, D; van Leer-Buter, CC, 2022)
"These persistent smell disorders greatly influence daily life."3.11COCOS trial: ( Boek, WM; Boesveldt, S; Kamalski, DMA; Schepens, EJA; Stegeman, I; Stokroos, RJ, 2022)
"We herein report two cases of coronavirus disease 2019 (COVID-19) vaccine-induced immune thrombocytopenia (ITP)."2.82Severe Immune Thrombocytopenia after COVID-19 Vaccination: Two Case Reports and a Literature Review. ( Kimura, F; Shonai, T; Watanabe, J, 2022)
"Treatment with leflunomide or low doses of glucocorticoids were not associated with severe course in our cohort."2.82COVID-19 among patients with giant cell arteritis: a single-centre observational study from Slovenia. ( Hočevar, A; Ješe, R; Kramarič, J; Rotar, Ž; Tomšič, M, 2022)
"A 61-year old patient with ankylosing spondylitis who was on secukinumab therapy for 5 months admitted with newly onset fever and gastrointestinal complaints."2.66Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review. ( Coskun Benlidayi, I; Guzel, R; Kurtaran, B; Tirasci, E, 2020)
"To compare the occurrence of sudden sensorineural hearing loss following immunization with BNT162b2 (Comirnaty®; Pfizer BioNTech) or mRNA-1273 (Spikevax®; Moderna) to the occurrence among unvaccinated individuals."1.91Sudden Sensorineural Hearing Loss Following Immunization With BNT162b2 or mRNA-1273: A Danish Population-Based Cohort Study. ( Cleary, B; Damkier, P; Hallas, J; Jensen, PB; Ladebo, L; Lund, LC; Schmidt, JH, 2023)
"He was diagnosed with acquired hemophilia A (AHA) based on factor VIII (FVIII) activity of 1."1.91[Acquired hemophilia A that developed after BNT162b2 mRNA COVID-19 vaccination and worsened following re-vaccination]. ( Akashi, N; Handa, H; Ichinose, A; Ishikawa, T; Kajita, M; Kobayashi, N; Koitabashi, R; Matsumoto, A; Miyazawa, Y; Naito, C; Ogawa, Y; Sorimachi, M; Souri, M, 2023)
"Mixed warm and cold autoimmune haemolytic anaemia (AIHA) secondary to COVID-19 is rarely reported."1.91Mixed autoimmune haemolytic anaemia in a COVID-19 patient. ( Ab Aziz, NAFAA; Mohd Shukri, N, 2023)
"Renal biopsy was performed, and minimal change disease was diagnosed."1.91New-onset minimal change disease following the Moderna COVID-19 vaccine. ( Fujisawa, H; Kobayashi, N; Kumagai, J; Tanabe, M, 2023)
"To prevent the spread of the coronavirus disease 2019 (COVID-19) pandemic, vaccines have been authorized for emergency use and implemented worldwide."1.91De Novo ANCA-Negative Pauci-Immune Crescentic Glomerulonephritis After COVID-19 mRNA Vaccination: A Case Report. ( Cho, H; Hwang, JH; Kim, SH; Lee, HS; Shin, J, 2023)
"The development of pulmonary fibrosis is a rare complication of the novel coronavirus disease 2019 (COVID-19)."1.72Clinical characteristics and outcomes of post-COVID-19 pulmonary fibrosis: A case-control study. ( Alamoudi, A; Alnami, A; Badedi, M; Farghaly, S; Ibrahim, R; Muhajir, A; Sadhan, MH, 2022)
"Acquired haemophilia A (AHA) is a rare bleeding disorder, characterised by the presence of autoantibodies to clotting factor VIII (FVIII)."1.72Acquired Hemophilia A following Pfizer-BioNTech SARS CoV-2 mRNA vaccine, successfully treated with prednisolone and rituximab. ( Gilbar, PJ; Mangos, HM; Murali, A; Wong, P, 2022)
" During the course of the study, patients were given standard treatment and an oral dose of 500 mg of RECOVEREEZ FORTE™ thrice daily, or standard of care and oral Prednisolone in tapered dosage (control group)."1.72Anti-inflammatory response of cardamom extract and prediction of therapeutic window in COVID-19 patients by assessing inflammatory markers using RT-PCR. ( Hynse, A; Mandlecha, A; Shakeeb, N; Varkey, P, 2022)
"We aimed to study the outcomes of coronavirus disease 2019 (COVID-19) in patients with a history of rheumatoid arthritis (RA) in Iran, where most patients receive corticosteroids and are at high risk for COVID-19 infection."1.72Outcomes of coronavirus disease 19 patients with a history of rheumatoid arthritis: A retrospective registry-based study in Iran. ( Movassaghi, S; Rostamian, A; Seyyedsalehi, MS; Zargaran, M; Zendehdel, K, 2022)
"001), with increases in poorly bioavailable oral corticosteroids in Crohn's (pandemic 15."1.72Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID-19 pandemic: the PREPARE-IBD multicentre cohort study. ( Bhala, N; Brookes, MJ; Conley, TE; Gonzalez, HA; Hicks, LC; Kennedy, NA; Kent, AJ; Lamb, CA; Mehta, SJ; Patel, KV; Saifuddin, A; Sebastian, S; Segal, JP; Subramanian, S; Walker, GJ, 2022)
"Steroids are one of the main treatments for ulcerative colitis; however, steroids work well for only about 50% of people who take them."1.72Patient preferences and current practice for adults with steroid-resistant ulcerative colitis: POPSTER mixed-methods study. ( Barr, A; Bedford, H; Blackwell, S; Coates, E; Dames, N; Hind, D; Lee, M; Lobo, A; Probert, C; Sebastian, S; Shackley, P; Totton, N; Wickramasekera, N, 2022)
"Bell's palsy is an acute facial paralysis with known association to viral infections."1.62Bell's palsy in a pediatric patient with hyper IgM syndrome and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). ( Itani, R; Santoro, JD; Theophanous, C, 2021)
"Thus, the condition was compatible with reactive arthritis."1.62Reactive arthritis after COVID-19. ( Hermansen, MF; Hønge, BL; Storgaard, M, 2021)
"The novel coronavirus disease 2019 (COVID-19) is a respiratory infection that has received much attention due to its rapid expansion."1.62COVID-19 progression in kidney transplant recipients: a single-center case series. ( Keykhaei, M; Mansouri, ES; Rahimzadeh, H; Razeghi, E; Zivari, E, 2021)
"Patients with coronavirus disease 2019 (COVID-19) from novel coronavirus (SARS-CoV-2) infection may present with immune thrombocytopenia (ITP)."1.62Immune thrombocytopenia following multisystem inflammatory syndrome in children (MIS-C) - a case series. ( Grimes, AB; Kok, EY; Muscal, E; Sexson Tejtel, SK; Srivaths, L; Vogel, TP, 2021)
"Myocarditis has been reported as a possible and rare adverse consequence of different vaccines, and its clinical presentation can range from influenza-like symptoms to acute heart failure."1.62Myocarditis After SARS-CoV-2 Vaccination: A Vaccine-Induced Reaction? ( Ascenti, G; Blandino, A; Booz, C; Carerj, ML; Cattafi, A; Cicero, G; D'Angelo, T; Mazziotti, S, 2021)
"Necrotizing scleritis was gradually improved over 3 months."1.62Anterior Scleritis Manifesting After Coronavirus Disease 2019: A Report of Two Cases. ( Esfandiari, H; Feizi, S; Meshksar, A; Naderi, A, 2021)
"Health-care providers worldwide in the coronavirus disease 2019 pandemic have been confronted with an unprecedented number of viral lung infections, with great variance in symptoms and severity."1.56Two Immunocompromised Patients With Diffuse Alveolar Hemorrhage as a Complication of Severe Coronavirus Disease 2019. ( Beyer, M; Fogarassy, P; Hellmich, B; Löffler, C; Mahrhold, J, 2020)
" For the treatment of COVID-19 pneumonia, systemic and in-depth investigation is needed to determine the timing and dosage of glucocorticoids needed to inhibit overwhelming inflammatory response and not the protective immune response to COVID-19 pneumonia."1.56Clinical efficacy of glucocorticoid on the treatment of patients with COVID-19 pneumonia: A single-center experience. ( Hu, Y; Hu, Z; Li, L; Peng, P; Wang, T; Wang, X; Zhang, Z, 2020)
"They also presented with pulmonary fibrosis findings, including traction bronchiectasis and marked lung volume reduction."1.56Coronavirus disease 2019-associated rapidly progressive organizing pneumonia with fibrotic feature: Two case reports. ( Akiyama, Y; Fukunaga, K; Hasegawa, N; Ishii, M; Kabata, H; Kaneko, Y; Kondo, Y; Lee, H; Okamori, S, 2020)
" We also comment on suggested dosing for patients who usually take modified release hydrocortisone or prednisolone."1.56ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of adrenal insufficiency. ( Arlt, W; Baldeweg, SE; Pearce, SHS; Simpson, HL, 2020)
"Prednisolone was tapered to 15 mg when current COVID-19 was suspected, considering his recent cough, dyspnea, and fever."1.56Mucous membrane pemphigoid and COVID-19 treated with high-dose intravenous immunoglobulins: a case report. ( Daneshpazhooh, M; Isazade, A; Noormohammadpour, P; Soori, T, 2020)
"Subacute thyroiditis is a self-limiting and painful thyroid gland inflammation most often secondary to viral infections."1.56Subacute thyroiditis as a presenting manifestation of COVID-19: a report of an exceedingly rare clinical entity. ( Chakraborty, U; Chandra, A; Ghosh, S; Ray, AK, 2020)

Research

Studies (103)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's103 (100.00)2.80

Authors

AuthorsStudies
Richardson-May, J1
Rothwell, A1
Rashid, M1
Yang, ST1
Yeh, CC1
Lee, WL1
Lee, FK1
Chang, CC1
Wang, PH1
Ghanei, M2
Solaymani-Dodaran, M1
Qazvini, A1
Ghazale, AH2
Setarehdan, SA1
Saadat, SH2
Ghobadi, H1
Hoseininia, S1
Elahikhah, M1
Samadi, AH1
Imani, Y1
Vahedi, E2
Babamahmoodi, F1
Rostami, FT1
Ardebili, MHA1
Ansarifar, A1
Golmaei, FF1
Asadollah, A1
Kawasaki, T1
Ooka, S1
Mizushima, M1
Nakamura, Y1
Ikeda, H1
Sakurada, T1
Suzuki, S1
Yamazaki, K1
Goto, Y1
Sakurai, K1
Yukitaka, Y1
Kiyokawa, T1
Tonooka, K1
Kunishima, H1
Kawahata, K1
Kaviani, A1
Khansari Nejad, N1
Akour, A1
AlMuhaissen, SA1
Nusair, MB1
Al-Tammemi, AB1
Mahmoud, NN1
Jalouqa, S1
Alrawashdeh, MN1
Shanahan, JP1
Moore, CM1
Kampf, JW1
Szymczak, NK1
Guo, J1
Wang, H1
Luo, Y1
An, H1
Zhang, Z3
Liu, G1
Li, J1
Metcalfe, GD1
Smith, TW1
Hippler, M1
Ayala Izurieta, JE1
Márquez, CO1
García, VJ1
Jara Santillán, CA1
Sisti, JM1
Pasqualotto, N1
Van Wittenberghe, S1
Delegido, J1
Kubo, Y1
Kitagawa, Y1
Miyazaki, T1
Sohda, M1
Yamaji, T1
Sakai, M1
Saeki, H1
Nemoto, K1
Oyama, T2
Muto, M1
Takeuchi, H1
Toh, Y1
Matsubara, H1
Mano, M1
Kono, K1
Kato, K1
Yoshida, M1
Kawakubo, H1
Booka, E1
Yamatsuji, T1
Kato, H1
Ito, Y1
Ishikawa, H1
Ishihara, R1
Tsushima, T1
Kawachi, H1
Kojima, T1
Kuribayashi, S1
Makino, T1
Matsuda, S1
Doki, Y1
Ma, P1
Tang, X1
Zhang, L2
Wang, X2
Wang, W1
Zhang, X1
Wang, S2
Zhou, N1
Dodd, J1
Jordan, R1
Makhlina, M1
Pesco Koplowitz, L1
Koplowitz, B1
Barnett, K1
Yang, WH1
Spana, C1
Buchanan, SW1
Mafa-Attoye, T1
Dunfield, K1
Thevathasan, NV1
Isaac, ME1
Wu, X2
Huang, JW1
Su, BK1
Yuan, L1
Zheng, WQ1
Zhang, H2
Zheng, YX1
Zhu, W1
Chou, PT1
Manso, AP1
De Morais, DC1
Yamamoto, K1
Owen, G1
de Carvalho, RM1
Palma-Dibb, RG1
Brown, JC1
Yang, S1
Mire, EF1
Miele, L1
Ochoa, A1
Zabaleta, J1
Katzmarzyk, PT1
Moi, CT1
Bhowmick, S1
Qureshi, M1
Wang, K1
Feng, B1
Yang, Y1
Chen, Y1
Wang, Y2
Yang, L1
Jiang, K1
James, TD1
Chaturvedi, V1
Postiglione, WM1
Chakraborty, RD1
Yu, B1
Tabiś, W1
Hameed, S1
Biniskos, N1
Jacobson, A1
Zhou, H1
Greven, M1
Ferry, VE1
Leighton, C1
Wu, F1
Lei, H1
Chen, G2
Chen, C1
Song, Y1
Cao, Z1
Zhang, C2
Zhou, J1
Lu, Y1
Pappone, C1
Santinelli, V1
Mecarocci, V1
Tondi, L1
Ciconte, G1
Manguso, F1
Sturla, F1
Vicedomini, G1
Micaglio, E1
Anastasia, L1
Pica, S1
Camporeale, A1
Lombardi, M1
Shieh, PB1
Elfring, G1
Trifillis, P1
Santos, C1
Peltz, SW1
Parsons, JA1
Apkon, S1
Darras, BT1
Campbell, C1
McDonald, CM1
Galaviz, KI1
Shah, NS1
Gutierrez, M1
Collins, LF1
Lahiri, CD1
Moran, CA1
Szabo, B1
Sumitani, J1
Rhodes, J1
Marconi, VC1
Nguyen, ML1
Cantos, VD1
Armstrong, WS1
Colasanti, JA1
Garrido, I1
Lopes, S1
Simões, MS1
Liberal, R1
Lopes, J1
Carneiro, F1
Macedo, G1
Khochtali, S1
Krifa, H1
Zina, S1
Khairallah, M2
Jelliti, B1
Abroug, N1
Chen, Q1
Yang, Q1
Fang, Y1
Lv, X1
Dhooria, S1
Chaudhary, S1
Sehgal, IS1
Agarwal, R1
Arora, S1
Garg, M1
Prabhakar, N1
Puri, GD1
Bhalla, A1
Suri, V1
Yaddanapudi, LN1
Muthu, V1
Prasad, KT1
Aggarwal, AN1
Altun, E1
Kuzucular, E1
Farghaly, S1
Badedi, M1
Ibrahim, R1
Sadhan, MH1
Alamoudi, A1
Alnami, A1
Muhajir, A1
Abdelhamid, NS1
Magdy, MA1
Anwar, BH1
Farid, NF1
Calis, H1
Karabulut, Z1
Guler, Y1
Sengul, S1
Murali, A1
Wong, P1
Gilbar, PJ1
Mangos, HM1
Shonai, T1
Kimura, F1
Watanabe, J1
Pagh, P1
Rossau, AK1
Shakeeb, N1
Varkey, P1
Hynse, A1
Mandlecha, A1
Kramarič, J1
Ješe, R1
Tomšič, M1
Rotar, Ž1
Hočevar, A1
Joo, CW1
Kim, YK1
Park, SP1
de Boer, SE1
Berger, SP1
van Leer-Buter, CC1
Kroesen, BJ1
van Baarle, D1
Sanders, JF1
McKeigue, PM1
Porter, D1
Hollick, RJ1
Ralston, SH1
McAllister, DA1
Colhoun, HM1
Matsumura, K1
Kawano, H1
Kurobe, M1
Akashi, R1
Yoshimuta, T1
Ikeda, S1
Ueki, N1
Nakashima, M1
Maemura, K1
Miyata, M1
Ooto, S1
Muraoka, Y1
Kumar, A2
Mishra, M1
Banerjee, S1
Saini, LK1
Sharma, P1
Dua, R1
Sindhwani, G1
Zargaran, M1
Movassaghi, S1
Seyyedsalehi, MS1
Zendehdel, K1
Rostamian, A1
Ito, C1
Odajima, K1
Niimura, Y1
Fujii, M1
Sone, M1
Asakawa, S1
Arai, S1
Yamazaki, O1
Tamura, Y1
Saito, K1
Tada, Y1
Yamamoto, T1
Kozuma, K1
Shibata, S1
Fujigaki, Y1
Schepens, EJA4
Boek, WM4
Boesveldt, S4
Stegeman, I4
Stokroos, RJ4
Kamalski, DMA4
Alharbi, AM1
Rabbani, SI1
Halim Mohamed, AA1
Almushayti, BK1
Aldhwayan, NI1
Almohaimeed, AT1
Alharbi, AA1
Alharbi, NS1
Asdaq, SMB1
Alamri, AS1
Alsanie, WF1
Alhomrani, M1
Mok, CC1
Chan, KL1
Tse, SM1
Yeoh, SA1
Gianfrancesco, M1
Lawson-Tovey, S1
Hyrich, KL1
Strangfeld, A1
Gossec, L1
Carmona, L1
Mateus, EF1
Schäfer, M1
Richez, C1
Hachulla, E1
Holmqvist, M1
Scirè, CA1
Lorenz, HM1
Voll, RE2
Hasseli, R1
Jayatilleke, A1
Hsu, TY1
D'Silva, KM1
Pimentel-Quiroz, VR1
Vasquez Del Mercado, M1
Shinjo, SK1
Neto, ETDR1
Junior, LFDR1
de Oliveira E Silva Montandon, AC1
Pons-Estel, GJ1
Ornella, S1
D'Angelo Exeni, ME1
Velozo, E1
Jordan, P1
Sirotich, E1
Hausmann, JS1
Liew, JW1
Jacobsohn, L1
Gore-Massy, M1
Sufka, P1
Grainger, R1
Bhana, S1
Wallace, Z1
Robinson, PC1
Yazdany, J1
Machado, PM1
Tunbridge, M1
Perkins, GB1
Singer, J1
Salehi, T1
Ying, T1
Grubor-Bauk, B1
Barry, S1
Sim, B1
Hissaria, P1
Chadban, SJ1
Coates, PT1
Toya, T1
Atsuta, Y1
Sanada, T1
Honda, T1
Sadato, D1
Sekiya, N1
Kogure, H1
Takakuwa, S1
Onai, D1
Shingai, N1
Shimizu, H1
Najima, Y1
Kobayashi, T1
Ohashi, K2
Harada, Y1
Kohara, M1
Doki, N1
Suzuki, M2
Sekiguchi, Y1
Sasaki, M1
Inaba, S1
Oyama, S1
Inoue, Y1
Warabi, M1
Inoshita, S1
Saifuddin, A1
Kent, AJ1
Mehta, SJ1
Hicks, LC1
Gonzalez, HA1
Segal, JP1
Brookes, MJ1
Subramanian, S1
Bhala, N1
Conley, TE1
Patel, KV1
Lamb, CA1
Walker, GJ1
Kennedy, NA1
Sebastian, S2
Tanaka, Y1
Hirano, K1
Sekino, E1
Shimane, T1
Kobayashi, H2
Coates, E1
Wickramasekera, N1
Barr, A1
Shackley, P1
Lee, M1
Hind, D1
Probert, C1
Totton, N1
Blackwell, S1
Bedford, H1
Dames, N1
Lobo, A1
Blijleven, EE3
Wong, CK3
Sia, LC3
Ooi, NZM3
Chan, WY3
Pang, YK3
Ma, M2
Santosa, A2
Fong, W2
Chew, LC2
Low, AH2
Law, A2
Poh, YJ2
Yeo, SI2
Leung, YY2
Ng, VW2
Koh, JZ2
Tay, SH2
Mak, A2
Teng, GG2
Xu, C2
Tang, JG2
Kong, KO2
Angkodjojo, S2
Goh, WR2
Chuah, TY2
Roslan, NE2
Arkachaisri, T2
Teh, KL2
Sriranganathan, M2
Tan, TC2
Phang, KF2
Yap, QV2
Chan, YH2
Cheung, PP2
Lahiri, M2
Loghman, M1
Rahmanian, E1
Alikhani, M1
Saffar, H1
Beikmohamadi Hezaveh, S1
Nekooeian, M1
Shahriarirad, R1
Faezi, ST1
Griffiths-Jones, DJ1
Garcia, YS1
Ryder, WD1
Pauling, JD1
Hall, F1
Lanyon, P1
Bhat, S1
Douglas, K1
Gunawardena, H1
Akil, M1
Anderson, M1
Griffiths, B1
Del Galdo, F1
Youssef, H1
Madhok, R1
Arthurs, B1
Buch, M1
Fligelstone, K1
Zubair, M1
Mason, JC1
Denton, CP1
Herrick, AL1
Sorimachi, M1
Ogawa, Y1
Matsumoto, A1
Souri, M1
Koitabashi, R1
Kajita, M1
Akashi, N1
Naito, C1
Ishikawa, T1
Kobayashi, N2
Miyazawa, Y1
Ichinose, A1
Handa, H1
Hagihara, M1
Sugi, T1
Hayashi, H1
Nakashima, S1
Ohara, S1
Imai, Y1
Nakano, H1
Uchida, T1
Inoue, M1
Mitamura, K1
Learoyd, AE1
Arnold, L1
Reid, F1
Beckley-Hoelscher, N1
Casian, A1
Sangle, S1
Morton, N1
Nel, L1
Cape, A1
John, S1
Kim, S1
Shivapatham, D1
Luqmani, R1
Jayne, D1
Galloway, J1
Douiri, A1
D'Cruz, D1
Ueno, M1
Takabatake, H1
Itakura, J1
Fujita, R1
Kayahara, T1
Morimoto, Y1
Notohara, K1
Mizuno, M1
Kimura, H1
Furukawa, M1
Shiga, Y1
Kai, T1
Yasuda, I1
Katoh, S1
Sando, E1
Mohd Shukri, N1
Ab Aziz, NAFAA1
Shimizu, R1
Sonoyama, T1
Fukuhara, T1
Kuwata, A1
Matsuzaki, T1
Matsuo, Y1
Kubota, R1
Damkier, P1
Cleary, B1
Hallas, J1
Schmidt, JH1
Ladebo, L1
Jensen, PB1
Lund, LC1
Fujisawa, H1
Kumagai, J1
Tanabe, M1
Ito, S1
Ikenouchi, T1
Yamamoto, H1
Takeuchi, S1
Ogawa, M1
Cho, H1
Lee, HS1
Kim, SH1
Shin, J1
Hwang, JH1
Daneshpazhooh, M2
Soori, T2
Isazade, A2
Noormohammadpour, P1
Arlt, W1
Baldeweg, SE1
Pearce, SHS1
Simpson, HL1
Grinspan, ZM1
Mytinger, JR1
Baumer, FM1
Ciliberto, MA1
Cohen, BH1
Dlugos, DJ1
Harini, C1
Hussain, SA1
Joshi, SM1
Keator, CG1
Knupp, KG1
McGoldrick, PE1
Nickels, KC1
Park, JT1
Pasupuleti, A1
Patel, AD1
Pomeroy, SL1
Shahid, AM1
Shellhaas, RA1
Shrey, DW1
Singh, RK1
Wolf, SM1
Yozawitz, EG1
Yuskaitis, CJ1
Waugh, JL1
Pearl, PL1
Lauterio, A1
Valsecchi, M1
Santambrogio, S1
De Carlis, R1
Merli, M1
Calini, A1
Centonze, L1
Buscemi, V1
Bottiroli, M1
Puoti, M1
Fumagalli, R1
De Carlis, L1
Coleman, H1
Snell, LB1
Simons, R1
Douthwaite, ST1
Lee, MJ1
Asfuroglu Kalkan, E1
Ates, I1
Ghazvini, A1
Azadi, H1
Izadi, M1
Panahi, Y1
Fathi, S1
Salesi, M1
Rezapour, M1
Mozafari, A1
Zand, N1
Parsaei, MR1
Ranjkesh, MH1
Jafari, R2
Movaseghi, F1
Darabi, E1
Coskun Benlidayi, I1
Kurtaran, B1
Tirasci, E1
Guzel, R1
Löffler, C1
Mahrhold, J1
Fogarassy, P1
Beyer, M1
Hellmich, B1
Monfared, A1
Dashti-Khavidaki, S1
Jafari, A1
Ramezanzade, E1
Lebadi, MK1
Haghdar-Saheli, Y1
Aghajanzadeh, P1
Khosravi, M1
Movassaghi, A1
Taghvaye-Masoumi, H1
Alavi Foumani, A1
Dahl Mathiasen, V1
Jensen-Fangel, S1
Skov, K1
Leth, S1
Kuzeva, A1
Dost, S1
Lams, B1
Agarwal, S1
Furmedge, DS1
Hu, Y1
Wang, T1
Hu, Z1
Li, L1
Peng, P1
Mattar, SAM1
Koh, SJQ1
Rama Chandran, S1
Cherng, BPZ1
Okamori, S1
Lee, H1
Kondo, Y1
Akiyama, Y1
Kabata, H1
Kaneko, Y1
Ishii, M1
Hasegawa, N1
Fukunaga, K1
Theophanous, C1
Santoro, JD1
Itani, R1
Schramm, MA1
Venhoff, N1
Wagner, D1
Thiel, J1
Huzly, D1
Craig-Mueller, N1
Panning, M1
Hengel, H1
Kern, WV1
Nofal, A1
Fawzy, MM1
Sharaf El Deen, SM1
El-Hawary, EE1
Koumpa, FS1
Forde, CT1
Manjaly, JG1
Tzukert, K1
Abel, R1
Mor Yosef Levi, I1
Gork, I1
Yosha Orpaz, L1
Azmanov, H1
Dranitzki Elhalel, M1
Chowdary, P1
Shetty, S2
Booth, J1
Khurram, MA1
Yaqoob, M1
Mohamed, IH1
Kim-Hellmuth, S1
Hermann, M1
Eilenberger, J1
Ley-Zaporozhan, J1
Fischer, M1
Hauck, F1
Klein, C1
Haas, N1
Kappler, M1
Huebner, J1
Jakob, A1
von Both, U1
Schenker, HM1
Hagen, M1
Simon, D1
Schett, G1
Manger, B1
Ahmadinejad, Z1
Assari, R1
Ayoobi Yazdi, N1
Mazloomi, SH1
Javanshayani, P1
Khalili Afousi, H1
Ziaee, V1
Querido, S1
Calça, R1
Weigert, A1
Francisco, D1
Adragão, T1
Ana Pessanha, M1
Gomes, P1
Rodrigues, L1
Figueira, JM1
Cardoso, C1
Machado, D1
Uda, K1
Okita, K1
Soneda, K1
Taniguchi, K1
Horikoshi, Y1
Pelle, MC1
Tassone, B1
Ricchio, M1
Mazzitelli, M1
Davoli, C1
Procopio, G1
Cancelliere, A1
La Gamba, V1
Lio, E1
Matera, G1
Quirino, A1
Barreca, GS1
Trecarichi, EM1
Torti, C1
Mahmoudi, H1
Farid, AS1
Nili, A1
Dayani, D1
Tavakolpour, S1
Teimourpour, A1
Abedini, R1
Balighi, K1
Chakraborty, U1
Ghosh, S1
Chandra, A1
Ray, AK1
Heron, VC1
Bach, CT1
Holmes, NE1
Whitlam, JB1
Hashim, M1
Athar, S1
Gaba, WH1
Looman, KIM1
Nuver, ME1
Korevaar, TIM1
Guillen, SS1
Takumida, H1
Izumi, S1
Sakamoto, K1
Hashimoto, M1
Ishii, S1
Takasaki, J1
Tanaka, M1
Igari, T1
Hojo, M1
Naser Moghadasi, A1
Shabany, M1
Heidari, H1
Eskandarieh, S1
Kumar, V1
Narayanan, P1
Mohammed, AP1
Hønge, BL1
Hermansen, MF1
Storgaard, M1
Singh, G1
Mathur, U1
Rahimzadeh, H1
Keykhaei, M1
Razeghi, E1
Zivari, E1
Mansouri, ES1
Wong Chung, JERE1
Engin, Ö1
Wolfs, TFW1
Renson, TJC1
de Boer, JH1
Aguilar-Gamboa, FR1
Cubas-Alarcon, D1
Villegas-Chiroque, M1
Failoc-Rojas, VE1
Kok, EY1
Srivaths, L1
Grimes, AB1
Vogel, TP1
Sexson Tejtel, SK1
Muscal, E1
Ashraf, S2
Imran, MA1
Hafsa, HT1
Khalid, S1
Akram, MK1
Ghufran, M1
Cheema, KK1
Ahmad, A1
Izhar, M1
Pareja-Ríos, A1
Bonaque-González, S1
D'Angelo, T1
Cattafi, A1
Carerj, ML1
Booz, C1
Ascenti, G1
Cicero, G1
Blandino, A1
Mazziotti, S1
Ohsawa, R1
Sano, H1
Ikeda, M1
Sano, S1
El Hasbani, G1
Taher, AT1
Jawad, ASM1
Uthman, I1
Karimi, N1
Okhovat, AA1
Ziaadini, B1
Haghi Ashtiani, B1
Nafissi, S1
Fatehi, F1
Vuille-Lessard, É1
Montani, M1
Bosch, J1
Semmo, N1
Sinha, R1
Wander, A1
Kapoor, A1
Yadav, R1
Gulati, S1
Feizi, S1
Meshksar, A1
Naderi, A1
Esfandiari, H1
Zhou, T1
Fronhoffs, F1
Dold, L1
Strassburg, CP1
Weismüller, TJ1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Comparison of the Efficacy and Safety of Two Corticosteroid Regimens in the Treatment of Diffuse Lung Disease After Coronavirus Disease 2019 (COVID-19) Pneumonia[NCT04657484]130 participants (Actual)Interventional2020-12-01Completed
Thyroid Function Tests and the Status of Thyroid Autoantibodies in Hospitalized Covid-19 Patients and Their Relationship With White Blood Cells, Neutrophil / Lymphocyte Ratio, c Reactive Protein, Fibrinogen, Procalcitonin, Ferritin and D-dimer[NCT04659200]20 participants (Actual)Observational2020-09-01Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

6 reviews available for prednisolone and 2019 Novel Coronavirus Disease

ArticleYear
    Biomaterial investigations in dentistry, 2021, Volume: 8, Issue:1

    Topics: Adult; Alcohol Drinking; Ammonia; Animals; Anti-Inflammatory Agents; Area Under Curve; B-Lymphocytes

2021
Severe Immune Thrombocytopenia after COVID-19 Vaccination: Two Case Reports and a Literature Review.
    Internal medicine (Tokyo, Japan), 2022, May-15, Volume: 61, Issue:10

    Topics: Adult; Aged; COVID-19; COVID-19 Vaccines; Female; Humans; Male; Prednisolone; Purpura, Thrombocytope

2022
COVID-19 among patients with giant cell arteritis: a single-centre observational study from Slovenia.
    Clinical rheumatology, 2022, Volume: 41, Issue:8

    Topics: Cardiovascular Diseases; COVID-19; Giant Cell Arteritis; Glucocorticoids; Humans; Hypertension; Lefl

2022
Corticosteroid-refractory autoimmune hepatitis after COVID-19 vaccination: a case report and literature review.
    Clinical journal of gastroenterology, 2023, Volume: 16, Issue:4

    Topics: Adrenal Cortex Hormones; Azathioprine; COVID-19; COVID-19 Vaccines; Female; Hepatitis, Autoimmune; H

2023
Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review.
    Rheumatology international, 2020, Volume: 40, Issue:10

    Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Antirheumatic Agents; Betacoronavirus; Coronaviru

2020
Experience of SARS-CoV-2 infection in two kidney transplant recipients living with HIV-1 infection.
    Transplant infectious disease : an official journal of the Transplantation Society, 2021, Volume: 23, Issue:2

    Topics: Adult; Anti-Bacterial Agents; Anti-HIV Agents; Atovaquone; CD4 Lymphocyte Count; CD4-CD8 Ratio; COVI

2021

Trials

9 trials available for prednisolone and 2019 Novel Coronavirus Disease

ArticleYear
The efficacy of corticosteroids therapy in patients with moderate to severe SARS-CoV-2 infection: a multicenter, randomized, open-label trial.
    Respiratory research, 2021, Sep-15, Volume: 22, Issue:1

    Topics: Adult; Aged; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Female;

2021
High-dose
    The European respiratory journal, 2022, Volume: 59, Issue:2

    Topics: COVID-19; Humans; Lung; Prednisolone; Respiration, Artificial; SARS-CoV-2; Treatment Outcome

2022
Enhanced Humoral Immune Response After COVID-19 Vaccination in Elderly Kidney Transplant Recipients on Everolimus Versus Mycophenolate Mofetil-containing Immunosuppressive Regimens.
    Transplantation, 2022, 08-01, Volume: 106, Issue:8

    Topics: Aged; Calcineurin Inhibitors; COVID-19; COVID-19 Vaccines; Everolimus; Humans; Immunity, Humoral; Im

2022
COCOS trial:
    BMJ open, 2022, 08-10, Volume: 12, Issue:8

    Topics: Adrenal Cortex Hormones; Anosmia; COVID-19; COVID-19 Testing; Humans; Olfaction Disorders; Prednisol

2022
Rapamycin and inulin for booster vaccine response stimulation (RIVASTIM)-rapamycin: study protocol for a randomised, controlled trial of immunosuppression modification with rapamycin to improve SARS-CoV-2 vaccine response in kidney transplant recipients.
    Trials, 2022, Sep-15, Volume: 23, Issue:1

    Topics: COVID-19; COVID-19 Vaccines; Humans; Immunoglobulin G; Immunosuppression Therapy; Immunosuppressive

2022
Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial.
    BMC medicine, 2022, 11-16, Volume: 20, Issue:1

    Topics: Adolescent; COVID-19; COVID-19 Drug Treatment; Humans; Olfaction Disorders; Prednisolone; Quality of

2022
Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial.
    BMC medicine, 2022, 11-16, Volume: 20, Issue:1

    Topics: Adolescent; COVID-19; COVID-19 Drug Treatment; Humans; Olfaction Disorders; Prednisolone; Quality of

2022
Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial.
    BMC medicine, 2022, 11-16, Volume: 20, Issue:1

    Topics: Adolescent; COVID-19; COVID-19 Drug Treatment; Humans; Olfaction Disorders; Prednisolone; Quality of

2022
Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial.
    BMC medicine, 2022, 11-16, Volume: 20, Issue:1

    Topics: Adolescent; COVID-19; COVID-19 Drug Treatment; Humans; Olfaction Disorders; Prednisolone; Quality of

2022
Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial.
    BMC medicine, 2022, 11-16, Volume: 20, Issue:1

    Topics: Adolescent; COVID-19; COVID-19 Drug Treatment; Humans; Olfaction Disorders; Prednisolone; Quality of

2022
Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial.
    BMC medicine, 2022, 11-16, Volume: 20, Issue:1

    Topics: Adolescent; COVID-19; COVID-19 Drug Treatment; Humans; Olfaction Disorders; Prednisolone; Quality of

2022
Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial.
    BMC medicine, 2022, 11-16, Volume: 20, Issue:1

    Topics: Adolescent; COVID-19; COVID-19 Drug Treatment; Humans; Olfaction Disorders; Prednisolone; Quality of

2022
Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial.
    BMC medicine, 2022, 11-16, Volume: 20, Issue:1

    Topics: Adolescent; COVID-19; COVID-19 Drug Treatment; Humans; Olfaction Disorders; Prednisolone; Quality of

2022
Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial.
    BMC medicine, 2022, 11-16, Volume: 20, Issue:1

    Topics: Adolescent; COVID-19; COVID-19 Drug Treatment; Humans; Olfaction Disorders; Prednisolone; Quality of

2022
A Phase II randomized controlled trial of oral prednisolone in early diffuse cutaneous systemic sclerosis (PRedSS).
    Rheumatology (Oxford, England), 2023, 09-01, Volume: 62, Issue:9

    Topics: COVID-19; Double-Blind Method; Humans; Pain; Pandemics; Prednisolone; Scleroderma, Diffuse; Treatmen

2023
The HAVEN study-hydroxychloroquine in ANCA vasculitis evaluation-a multicentre, randomised, double-blind, placebo-controlled trial: study protocol and statistical analysis plan.
    Trials, 2023, Apr-06, Volume: 24, Issue:1

    Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic;

2023
Evaluation of the Drug-Drug Interaction Potential of Ensitrelvir Fumaric Acid with Cytochrome P450 3A Substrates in Healthy Japanese Adults.
    Clinical drug investigation, 2023, Volume: 43, Issue:5

    Topics: Adult; Area Under Curve; COVID-19; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dexame

2023

Other Studies

88 other studies available for prednisolone and 2019 Novel Coronavirus Disease

ArticleYear
Reactivation of herpes simplex keratitis following vaccination for COVID-19.
    BMJ case reports, 2021, Sep-07, Volume: 14, Issue:9

    Topics: Acyclovir; Aged, 80 and over; Antiviral Agents; COVID-19; Humans; Keratitis, Herpetic; Male; Prednis

2021
A symptomatic near-term pregnant woman recovered from SARS-CoV-2 infection.
    Taiwanese journal of obstetrics & gynecology, 2021, Volume: 60, Issue:5

    Topics: Adult; Apgar Score; Cesarean Section; COVID-19; Female; Glucocorticoids; Humans; Infant, Newborn; Ox

2021
COVID-19 and adult-onset Still's disease as part of hyperferritinemic syndromes.
    Modern rheumatology case reports, 2022, 01-07, Volume: 6, Issue:1

    Topics: Adult; Antibodies, Monoclonal, Humanized; COVID-19; COVID-19 Drug Treatment; Ferritins; Humans; Macr

2022
Autoimmune hepatitis after COVID-19 vaccine - more than a coincidence.
    Journal of autoimmunity, 2021, Volume: 125

    Topics: Antibodies, Antinuclear; Bilirubin; BNT162 Vaccine; COVID-19; Female; Fibrosis; Hepatitis, Autoimmun

2021
Multimodal Imaging of Acute Foveolitis following COVID-19 Vaccination.
    Ocular immunology and inflammation, 2022, Volume: 30, Issue:5

    Topics: COVID-19; COVID-19 Vaccines; Eye Diseases; Female; Fluorescein Angiography; Humans; Multimodal Imagi

2022
Potential benefits of precise corticosteroid therapy for critical COVID-19.
    Respiratory physiology & neurobiology, 2022, Volume: 297

    Topics: Adrenal Cortex Hormones; Aged; C-Reactive Protein; COVID-19; COVID-19 Drug Treatment; Critical Illne

2022
Leukocytoclastic vasculitis after COVID-19 vaccination.
    Dermatologic therapy, 2022, Volume: 35, Issue:3

    Topics: Adult; BNT162 Vaccine; COVID-19; Histamine Antagonists; Humans; Male; Prednisolone; SARS-CoV-2; Vacc

2022
Clinical characteristics and outcomes of post-COVID-19 pulmonary fibrosis: A case-control study.
    Medicine, 2022, Jan-21, Volume: 101, Issue:3

    Topics: Adrenal Cortex Hormones; Anticoagulants; Case-Control Studies; Cough; COVID-19; Dyspnea; Female; Fev

2022
US FDA-validated TLC method with four greenness assessment evaluations for simultaneous determination of prednisolone and esomeprazole in spiked human plasma.
    Biomedical chromatography : BMC, 2022, Volume: 36, Issue:5

    Topics: Chromatography, Thin Layer; COVID-19; Esomeprazole; Humans; Prednisolone; Reproducibility of Results

2022
Idiopathic granulomatous mastitis and steroid use during the pandemic of COVID-19.
    Breast disease, 2022, Volume: 41, Issue:1

    Topics: Adult; COVID-19; Female; Granulomatous Mastitis; Humans; Middle Aged; Prednisolone; Retrospective St

2022
Acquired Hemophilia A following Pfizer-BioNTech SARS CoV-2 mRNA vaccine, successfully treated with prednisolone and rituximab.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2022, Volume: 28, Issue:6

    Topics: Aged, 80 and over; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Factor VIII; Female; Hemoph

2022
[COVID-19 induced Stevens-Johnson syndrome].
    Ugeskrift for laeger, 2022, 03-07, Volume: 184, Issue:10

    Topics: COVID-19; Humans; Prednisolone; SARS-CoV-2; Stevens-Johnson Syndrome; Vaccination

2022
Anti-inflammatory response of cardamom extract and prediction of therapeutic window in COVID-19 patients by assessing inflammatory markers using RT-PCR.
    Inflammopharmacology, 2022, Volume: 30, Issue:3

    Topics: Anti-Inflammatory Agents; C-Reactive Protein; COVID-19; COVID-19 Drug Treatment; Elettaria; Humans;

2022
Vogt-Koyanagi-Harada Disease following mRNA-1273 (Moderna) COVID-19 Vaccination.
    Ocular immunology and inflammation, 2022, Volume: 30, Issue:5

    Topics: 2019-nCoV Vaccine mRNA-1273; COVID-19; Female; Humans; Middle Aged; Prednisolone; Retinal Detachment

2022
Risk of severe COVID-19 in patients with inflammatory rheumatic diseases treated with immunosuppressive therapy in Scotland.
    Scandinavian journal of rheumatology, 2023, Volume: 52, Issue:4

    Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Case-Control Studies; COVID-19; Humans; Immunosuppressi

2023
Delayed Acute Perimyocarditis and Bilateral Facial Nerve Palsy in a Patient with COVID-19.
    Internal medicine (Tokyo, Japan), 2022, Aug-01, Volume: 61, Issue:15

    Topics: Adult; COVID-19; Facial Nerve; Facial Paralysis; Humans; Male; Prednisolone

2022
Punctate inner choroidopathy immediately after COVID-19 infection: a case report.
    BMC ophthalmology, 2022, Jul-07, Volume: 22, Issue:1

    Topics: Adult; Choroid Diseases; COVID-19; Female; Fluorescein Angiography; Humans; Prednisolone; Tomography

2022
Clinical Profile, Risk Factors, and Therapeutic Outcome of Cavitating Fungal Pneumonia Coinfection in COVID-19 Patients: A Retrospective Analysis.
    Recent advances in anti-infective drug discovery, 2022, Volume: 17, Issue:3

    Topics: Coinfection; COVID-19; Female; Humans; Influenza, Human; Male; Middle Aged; Pneumonia; Prednisolone;

2022
Outcomes of coronavirus disease 19 patients with a history of rheumatoid arthritis: A retrospective registry-based study in Iran.
    International journal of rheumatic diseases, 2022, Volume: 25, Issue:10

    Topics: Adrenal Cortex Hormones; Arthritis, Rheumatoid; COVID-19; Female; Humans; Iran; Middle Aged; Prednis

2022
IgA vasculitis with transient glomerular hematuria, diarrhea, and pericarditis following COVID-19 mRNA vaccination in a young patient with possible pre-existing ulcerative colitis.
    CEN case reports, 2023, Volume: 12, Issue:1

    Topics: Antibodies, Antineutrophil Cytoplasmic; Colitis, Ulcerative; COVID-19; COVID-19 Vaccines; Diarrhea;

2023
Analysis of potential risk factors associated with COVID-19 and hospitalization.
    Frontiers in public health, 2022, Volume: 10

    Topics: COVID-19; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Hospitalization; Humans; Hyper

2022
Hesitancy for SARS-CoV-2 vaccines and post-vaccination flares in patients with systemic lupus erythematosus.
    Vaccine, 2022, 09-29, Volume: 40, Issue:41

    Topics: Adult; Arthritis; COVID-19; COVID-19 Vaccines; Female; Humans; Lupus Erythematosus, Systemic; Male;

2022
Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry.
    RMD open, 2022, Volume: 8, Issue:2

    Topics: Adult; COVID-19; COVID-19 Testing; Female; Humans; Male; Myositis; Physicians; Prednisolone; Registr

2022
Attenuated humoral response against SARS-CoV-2 mRNA vaccination in allogeneic stem cell transplantation recipients.
    Cancer science, 2023, Volume: 114, Issue:2

    Topics: Adult; Antibodies, Viral; COVID-19; Cytomegalovirus Infections; Hematopoietic Stem Cell Transplantat

2023
Antineutrophil Cytoplasmic Antibody-associated Vasculitis after COVID-19 Vaccination with Pfizer-BioNTech.
    Internal medicine (Tokyo, Japan), 2022, Volume: 61, Issue:19

    Topics: Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytopla

2022
Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID-19 pandemic: the PREPARE-IBD multicentre cohort study.
    Alimentary pharmacology & therapeutics, 2022, Volume: 56, Issue:10

    Topics: Adrenal Cortex Hormones; Cohort Studies; Colitis, Ulcerative; COVID-19; Crohn Disease; Humans; Infla

2022
Case Report: A 29-Year-Old Pregnant Woman at 24 Weeks of Gestation Presenting with Laryngotracheitis and COVID-19 Due to the R.1 Variant of SARS-CoV-2.
    The American journal of case reports, 2022, Oct-18, Volume: 23

    Topics: Adult; Cough; COVID-19; Croup; Epinephrine; Female; Humans; Prednisolone; Pregnancy; Pregnant Women;

2022
Patient preferences and current practice for adults with steroid-resistant ulcerative colitis: POPSTER mixed-methods study.
    Health technology assessment (Winchester, England), 2022, Volume: 26, Issue:41

    Topics: Adult; Colitis, Ulcerative; Cost-Benefit Analysis; COVID-19; Humans; Infliximab; Neoplasm Recurrence

2022
Severe COVID-19 with persistent respiratory failure-A retrospective cohort study in a tertiary centre in Malaysia.
    PloS one, 2022, Volume: 17, Issue:11

    Topics: Adrenal Cortex Hormones; Cohort Studies; COVID-19; Humans; Malaysia; Pneumonia; Prednisolone; Respir

2022
Severe COVID-19 with persistent respiratory failure-A retrospective cohort study in a tertiary centre in Malaysia.
    PloS one, 2022, Volume: 17, Issue:11

    Topics: Adrenal Cortex Hormones; Cohort Studies; COVID-19; Humans; Malaysia; Pneumonia; Prednisolone; Respir

2022
Severe COVID-19 with persistent respiratory failure-A retrospective cohort study in a tertiary centre in Malaysia.
    PloS one, 2022, Volume: 17, Issue:11

    Topics: Adrenal Cortex Hormones; Cohort Studies; COVID-19; Humans; Malaysia; Pneumonia; Prednisolone; Respir

2022
Severe COVID-19 with persistent respiratory failure-A retrospective cohort study in a tertiary centre in Malaysia.
    PloS one, 2022, Volume: 17, Issue:11

    Topics: Adrenal Cortex Hormones; Cohort Studies; COVID-19; Humans; Malaysia; Pneumonia; Prednisolone; Respir

2022
Severe COVID-19 with persistent respiratory failure-A retrospective cohort study in a tertiary centre in Malaysia.
    PloS one, 2022, Volume: 17, Issue:11

    Topics: Adrenal Cortex Hormones; Cohort Studies; COVID-19; Humans; Malaysia; Pneumonia; Prednisolone; Respir

2022
Severe COVID-19 with persistent respiratory failure-A retrospective cohort study in a tertiary centre in Malaysia.
    PloS one, 2022, Volume: 17, Issue:11

    Topics: Adrenal Cortex Hormones; Cohort Studies; COVID-19; Humans; Malaysia; Pneumonia; Prednisolone; Respir

2022
Severe COVID-19 with persistent respiratory failure-A retrospective cohort study in a tertiary centre in Malaysia.
    PloS one, 2022, Volume: 17, Issue:11

    Topics: Adrenal Cortex Hormones; Cohort Studies; COVID-19; Humans; Malaysia; Pneumonia; Prednisolone; Respir

2022
Severe COVID-19 with persistent respiratory failure-A retrospective cohort study in a tertiary centre in Malaysia.
    PloS one, 2022, Volume: 17, Issue:11

    Topics: Adrenal Cortex Hormones; Cohort Studies; COVID-19; Humans; Malaysia; Pneumonia; Prednisolone; Respir

2022
Severe COVID-19 with persistent respiratory failure-A retrospective cohort study in a tertiary centre in Malaysia.
    PloS one, 2022, Volume: 17, Issue:11

    Topics: Adrenal Cortex Hormones; Cohort Studies; COVID-19; Humans; Malaysia; Pneumonia; Prednisolone; Respir

2022
Post-mRNA vaccine flares in autoimmune inflammatory rheumatic diseases: Results from the COronavirus National Vaccine registry for ImmuNe diseases SINGapore (CONVIN-SING).
    Journal of autoimmunity, 2023, Volume: 134

    Topics: Arthritis, Rheumatoid; Autoimmune Diseases; Child; Coronavirus; COVID-19; COVID-19 Vaccines; Female;

2023
Post-mRNA vaccine flares in autoimmune inflammatory rheumatic diseases: Results from the COronavirus National Vaccine registry for ImmuNe diseases SINGapore (CONVIN-SING).
    Journal of autoimmunity, 2023, Volume: 134

    Topics: Arthritis, Rheumatoid; Autoimmune Diseases; Child; Coronavirus; COVID-19; COVID-19 Vaccines; Female;

2023
Post-mRNA vaccine flares in autoimmune inflammatory rheumatic diseases: Results from the COronavirus National Vaccine registry for ImmuNe diseases SINGapore (CONVIN-SING).
    Journal of autoimmunity, 2023, Volume: 134

    Topics: Arthritis, Rheumatoid; Autoimmune Diseases; Child; Coronavirus; COVID-19; COVID-19 Vaccines; Female;

2023
Post-mRNA vaccine flares in autoimmune inflammatory rheumatic diseases: Results from the COronavirus National Vaccine registry for ImmuNe diseases SINGapore (CONVIN-SING).
    Journal of autoimmunity, 2023, Volume: 134

    Topics: Arthritis, Rheumatoid; Autoimmune Diseases; Child; Coronavirus; COVID-19; COVID-19 Vaccines; Female;

2023
Necrotizing autoimmune myositis following coronavirus disease 2019 infection: a case report.
    Journal of medical case reports, 2022, Dec-27, Volume: 16, Issue:1

    Topics: Aged; Autoimmune Diseases; COVID-19; Humans; Male; Muscle Weakness; Myositis; Prednisolone; SARS-CoV

2022
[Acquired hemophilia A that developed after BNT162b2 mRNA COVID-19 vaccination and worsened following re-vaccination].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2023, Volume: 64, Issue:1

    Topics: Activities of Daily Living; Aged, 80 and over; BNT162 Vaccine; COVID-19; Factor VIII; Hemophilia A;

2023
[Analysis of anti-SARS-CoV-2 IgG antibody titers after mRNA booster vaccination in patients with nonmalignant hematological disorders].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2023, Volume: 64, Issue:2

    Topics: Anemia, Aplastic; Antibodies, Viral; COVID-19; Hematologic Diseases; Humans; Immunoglobulin G; Predn

2023
Exacerbation of autoimmune hemolytic anemia associated with pure red cell aplasia after COVID-19: A case report.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2023, Volume: 29, Issue:8

    Topics: Adult; Anemia, Hemolytic, Autoimmune; Bone Marrow; COVID-19; Humans; Male; Prednisolone; Red-Cell Ap

2023
Mixed autoimmune haemolytic anaemia in a COVID-19 patient.
    The Malaysian journal of pathology, 2023, Volume: 45, Issue:1

    Topics: Aged; Anemia, Hemolytic, Autoimmune; COVID-19; Female; Humans; Prednisolone

2023
Sudden Sensorineural Hearing Loss Following Immunization With BNT162b2 or mRNA-1273: A Danish Population-Based Cohort Study.
    Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2023, Volume: 169, Issue:6

    Topics: 2019-nCoV Vaccine mRNA-1273; Adult; BNT162 Vaccine; Cohort Studies; COVID-19; COVID-19 Vaccines; Den

2023
New-onset minimal change disease following the Moderna COVID-19 vaccine.
    BMJ case reports, 2023, Sep-15, Volume: 16, Issue:9

    Topics: 2019-nCoV Vaccine mRNA-1273; COVID-19; COVID-19 Vaccines; Humans; Male; Nephrosis, Lipoid; Prednisol

2023
[Autoimmune hemolytic anemia following the third dose of the COVID-19 vaccine].
    Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 2023, Volume: 60, Issue:3

    Topics: 2019-nCoV Vaccine mRNA-1273; Aged; Anemia, Hemolytic, Autoimmune; COVID-19; COVID-19 Vaccines; Femal

2023
De Novo ANCA-Negative Pauci-Immune Crescentic Glomerulonephritis After COVID-19 mRNA Vaccination: A Case Report.
    Journal of Korean medical science, 2023, Oct-23, Volume: 38, Issue:41

    Topics: Antibodies, Antineutrophil Cytoplasmic; BNT162 Vaccine; COVID-19; COVID-19 Vaccines; Glomerulonephri

2023
Mucous membrane pemphigoid and COVID-19 treated with high-dose intravenous immunoglobulins: a case report.
    The Journal of dermatological treatment, 2020, Volume: 31, Issue:5

    Topics: Adult; Anti-Bacterial Agents; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; C

2020
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of adrenal insufficiency.
    European journal of endocrinology, 2020, Volume: 183, Issue:1

    Topics: Acute Disease; Adrenal Insufficiency; Adult; Betacoronavirus; Child; Child, Preschool; Coronavirus I

2020
Crisis Standard of Care: Management of Infantile Spasms during COVID-19.
    Annals of neurology, 2020, Volume: 88, Issue:2

    Topics: Adrenocorticotropic Hormone; Anticonvulsants; Betacoronavirus; Coronavirus Infections; COVID-19; Del

2020
Successful recovery from severe COVID-19 pneumonia after kidney transplantation: The interplay between immunosuppression and novel therapy including tocilizumab.
    Transplant infectious disease : an official journal of the Transplantation Society, 2020, Volume: 22, Issue:5

    Topics: Antibodies, Monoclonal, Humanized; Antiviral Agents; COVID-19; Drug Therapy, Combination; Female; Gr

2020
Coronavirus disease 2019 and Pneumocystis jirovecii pneumonia: a diagnostic dilemma in HIV.
    AIDS (London, England), 2020, 07-01, Volume: 34, Issue:8

    Topics: Anti-Bacterial Agents; Anti-HIV Agents; Asthma; Betacoronavirus; Clinical Laboratory Techniques; Cor

2020
A case of subacute thyroiditis associated with Covid-19 infection.
    Journal of endocrinological investigation, 2020, Volume: 43, Issue:8

    Topics: Adult; Anti-Inflammatory Agents; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; C

2020
The clinical value of two combination regimens in the Management of Patients Suffering from Covid-19 pneumonia: a single centered, retrospective, observational study.
    Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences, 2020, Volume: 28, Issue:2

    Topics: Adult; Aged; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Therapy, Combi

2020
Two Immunocompromised Patients With Diffuse Alveolar Hemorrhage as a Complication of Severe Coronavirus Disease 2019.
    Chest, 2020, Volume: 158, Issue:5

    Topics: Aged; Aortitis; Autoimmune Diseases; Betacoronavirus; Carcinoma, Transitional Cell; Chemoradiotherap

2020
Clinical characteristics and outcome of COVID-19 pneumonia in kidney transplant recipients in Razi hospital, Rasht, Iran.
    Transplant infectious disease : an official journal of the Transplantation Society, 2020, Volume: 22, Issue:6

    Topics: Acute Kidney Injury; Adult; Chills; Cough; COVID-19; COVID-19 Drug Treatment; Dyspnea; Female; Fever

2020
Uneventful case of COVID-19 in a kidney transplant recipient.
    BMJ case reports, 2020, Jul-20, Volume: 13, Issue:7

    Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Female; Glucocorticoids; Hospitalization; Humans;

2020
Time-critical administration of corticosteroid rescue therapy for COVID-19 pneumonitis in a ward-based patient with chronic obstructive pulmonary disease.
    British journal of hospital medicine (London, England : 2005), 2020, 07-02, Volume: 81, Issue:7

    Topics: Aged; Betacoronavirus; C-Reactive Protein; Clinical Deterioration; Coronavirus Infections; COVID-19;

2020
Clinical efficacy of glucocorticoid on the treatment of patients with COVID-19 pneumonia: A single-center experience.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 130

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Betacoronavirus; Clinical Laboratory Techniques; Coinfec

2020
Subacute thyroiditis associated with COVID-19.
    BMJ case reports, 2020, Aug-25, Volume: 13, Issue:8

    Topics: Adult; Betacoronavirus; Coronavirus Infections; COVID-19; Diagnosis, Differential; Glucocorticoids;

2020
Coronavirus disease 2019-associated rapidly progressive organizing pneumonia with fibrotic feature: Two case reports.
    Medicine, 2020, Aug-28, Volume: 99, Issue:35

    Topics: Antiviral Agents; Coronavirus Infections; COVID-19; Disease Progression; Dose-Response Relationship,

2020
Bell's palsy in a pediatric patient with hyper IgM syndrome and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
    Brain & development, 2021, Volume: 43, Issue:2

    Topics: Abnormalities, Multiple; Acyclovir; Antiviral Agents; Asthma; Bell Palsy; Child; Cleft Palate; COVID

2021
COVID-19 in a Severely Immunosuppressed Patient With Life-Threatening Eosinophilic Granulomatosis With Polyangiitis.
    Frontiers in immunology, 2020, Volume: 11

    Topics: Adult; Antiviral Agents; Betacoronavirus; Churg-Strauss Syndrome; Coronavirus Infections; COVID-19;

2020
Herpes zoster ophthalmicus in COVID-19 patients.
    International journal of dermatology, 2020, Volume: 59, Issue:12

    Topics: Acyclovir; Administration, Cutaneous; Administration, Oral; Adult; Antiviral Agents; Betacoronavirus

2020
Sudden irreversible hearing loss post COVID-19.
    BMJ case reports, 2020, Oct-13, Volume: 13, Issue:11

    Topics: Administration, Oral; Betacoronavirus; Coronavirus Infections; COVID-19; Glucocorticoids; Hearing Lo

2020
The Challenge of Treating Kidney Transplant Recipients Infected with COVID-19: Report of the First Cases in Israel.
    The Israel Medical Association journal : IMAJ, 2020, Volume: 22, Issue:10

    Topics: Anti-Infective Agents; Azithromycin; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus In

2020
SARS-CoV-2 Triggering Severe Acute Respiratory Distress Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in a 3-Year-Old Child With Down Syndrome.
    Journal of the Pediatric Infectious Diseases Society, 2021, Apr-30, Volume: 10, Issue:4

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Child, Preschool; COVID-19; COVID-19 Drug Treatm

2021
Reactive arthritis and cutaneous vasculitis after SARS-CoV-2 infection.
    Rheumatology (Oxford, England), 2021, 01-05, Volume: 60, Issue:1

    Topics: Aged; Antibodies, Viral; Arthritis, Reactive; C-Reactive Protein; COVID-19; COVID-19 Serological Tes

2021
COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?
    Reumatismo, 2020, Nov-19, Volume: 72, Issue:3

    Topics: Adalimumab; Adult; Antirheumatic Agents; Antiviral Agents; Arthritis, Rheumatoid; Azathioprine; Beta

2020
Kinetics of torquetenovirus DNA load in a recent kidney transplant recipient with mild SARS-CoV-2 infection and a failed antibody response.
    Transplant infectious disease : an official journal of the Transplantation Society, 2021, Volume: 23, Issue:2

    Topics: Adult; Antibodies, Viral; Comorbidity; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Serological

2021
Kawasaki disease following coronavirus disease 2019 with prolonged fecal viral shedding.
    Pediatrics international : official journal of the Japan Pediatric Society, 2021, Volume: 63, Issue:5

    Topics: Anti-Inflammatory Agents; COVID-19; Feces; Humans; Immunoglobulins, Intravenous; Immunologic Factors

2021
Late-onset myocardial infarction and autoimmune haemolytic anaemia in a COVID-19 patient without respiratory symptoms, concomitant with a paradoxical increase in inflammatory markers: a case report.
    Journal of medical case reports, 2020, Dec-18, Volume: 14, Issue:1

    Topics: Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Asymptomatic Infections; Az

2020
Characteristics and outcomes of COVID-19 in patients with autoimmune bullous diseases: A retrospective cohort study.
    Journal of the American Academy of Dermatology, 2021, Volume: 84, Issue:4

    Topics: Adult; Anti-Inflammatory Agents; Autoimmune Diseases; COVID-19; Female; Hospitalization; Humans; Imm

2021
Subacute thyroiditis as a presenting manifestation of COVID-19: a report of an exceedingly rare clinical entity.
    BMJ case reports, 2020, Dec-18, Volume: 13, Issue:12

    Topics: Amides; Antiviral Agents; Azithromycin; COVID-19; COVID-19 Drug Treatment; Diagnosis, Differential;

2020
Complete recovery from COVID-19 of a kidney-pancreas transplant recipient: potential benefit from everolimus?
    BMJ case reports, 2021, Jan-11, Volume: 14, Issue:1

    Topics: Accidents, Traffic; Asthma; COVID-19; Diabetes Mellitus, Type 1; Everolimus; Fever; Fibrin Fibrinoge

2021
New onset adrenal insufficiency in a patient with COVID-19.
    BMJ case reports, 2021, Jan-18, Volume: 14, Issue:1

    Topics: Acidosis; Adrenal Insufficiency; COVID-19; Fluid Therapy; Glucocorticoids; Humans; Hydrocortisone; H

2021
Hypereosinophilic syndrome with multiorgan involvement: an interdisciplinary work-up.
    BMJ case reports, 2021, Feb-04, Volume: 14, Issue:2

    Topics: Adult; Anti-Inflammatory Agents; Biopsy; COVID-19; Diagnosis, Differential; Dyspnea; Eosinophils; Hu

2021
Sustained coronavirus disease 2019-related organizing pneumonia successfully treated with corticosteroid.
    Respiratory investigation, 2021, Volume: 59, Issue:3

    Topics: Administration, Oral; Aged; Biomarkers; COVID-19; COVID-19 Drug Treatment; Humans; Lung; Male; Oxyge

2021
Can pulse steroid therapy increase the risk of infection by COVID-19 in patients with multiple sclerosis?
    Clinical neurology and neurosurgery, 2021, Volume: 203

    Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; COVID-19; Cross-Sectional Studies; Female;

2021
Lower motor neuron facial palsy in a postnatal mother with COVID-19.
    BMJ case reports, 2021, Mar-01, Volume: 14, Issue:3

    Topics: Adult; Anti-Inflammatory Agents; Antiviral Agents; Bell Palsy; COVID-19; Diagnosis, Differential; Fa

2021
Reactive arthritis after COVID-19.
    BMJ case reports, 2021, Mar-02, Volume: 14, Issue:3

    Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Arthritis; Arthritis,

2021
Acute graft rejection in a COVID-19 patient: Co-incidence or causal association?
    Indian journal of ophthalmology, 2021, Volume: 69, Issue:4

    Topics: Acute Disease; Adult; Cataract Extraction; Corneal Diseases; COVID-19; COVID-19 Drug Treatment; COVI

2021
COVID-19 progression in kidney transplant recipients: a single-center case series.
    CEN case reports, 2021, Volume: 10, Issue:4

    Topics: Acute Kidney Injury; Adult; Antimalarials; Antiviral Agents; COVID-19; Disease Progression; Female;

2021
Anterior uveitis in paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2.
    Lancet (London, England), 2021, 04-03, Volume: 397, Issue:10281

    Topics: Anti-Inflammatory Agents; Child; COVID-19; Humans; Male; Ophthalmic Solutions; Prednisolone; SARS-Co

2021
Pityriasis rubra pilaris post-infection due COVID-19: case report.
    Colombia medica (Cali, Colombia), 2021, Mar-18, Volume: 52, Issue:1

    Topics: Cetirizine; Child, Preschool; COVID-19; Glucocorticoids; Humans; Immunoglobulin G; Male; Pityriasis

2021
Immune thrombocytopenia following multisystem inflammatory syndrome in children (MIS-C) - a case series.
    Pediatric hematology and oncology, 2021, Volume: 38, Issue:7

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; COVID-19; Disease Management; Glucocorticoi

2021
COVID-19: A Potential Trigger for Thyroid Dysfunction.
    The American journal of the medical sciences, 2021, Volume: 362, Issue:3

    Topics: Anti-Inflammatory Agents; C-Reactive Protein; COVID-19; COVID-19 Drug Treatment; Glucocorticoids; Hu

2021
Late Corneal Stromal Deposits After COVID-19.
    Cornea, 2021, 08-01, Volume: 40, Issue:8

    Topics: Corneal Diseases; Corneal Stroma; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing;

2021
Myocarditis After SARS-CoV-2 Vaccination: A Vaccine-Induced Reaction?
    The Canadian journal of cardiology, 2021, Volume: 37, Issue:10

    Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Anti-Inflammatory Agents; Aspirin; Bisoprolol; BNT162

2021
Clinical and histopathological views of morbilliform rash after COVID-19 mRNA vaccination mimic those in SARS-CoV-2 virus infection-associated cutaneous manifestations.
    Journal of dermatological science, 2021, Volume: 103, Issue:2

    Topics: Administration, Oral; Biopsy; BNT162 Vaccine; COVID-19; COVID-19 Vaccines; Diagnosis, Differential;

2021
Henoch-Schönlein purpura: Another COVID-19 complication.
    Pediatric dermatology, 2021, Volume: 38, Issue:5

    Topics: Adolescent; Child; COVID-19; Humans; IgA Vasculitis; Male; Pain; Prednisolone; SARS-CoV-2

2021
Myasthenia gravis associated with novel coronavirus 2019 infection: A report of three cases.
    Clinical neurology and neurosurgery, 2021, Volume: 208

    Topics: Adult; Anti-Inflammatory Agents; Autoantibodies; Autoantigens; Cholinesterase Inhibitors; COVID-19;

2021
Autoimmune hepatitis triggered by SARS-CoV-2 vaccination.
    Journal of autoimmunity, 2021, Volume: 123

    Topics: 2019-nCoV Vaccine mRNA-1273; Aged; Autoantibodies; Azathioprine; Carcinoma, Transitional Cell; Causa

2021
Acute Demyelinating Syndrome (MOG Antibody Positive) Associated With COVID-19 Infection: A Widening spectrum.
    Clinical pediatrics, 2021, Volume: 60, Issue:13

    Topics: Acute Disease; Brain; Child; COVID-19; COVID-19 Drug Treatment; Demyelinating Diseases; Female; Gluc

2021
Anterior Scleritis Manifesting After Coronavirus Disease 2019: A Report of Two Cases.
    Cornea, 2021, Sep-01, Volume: 40, Issue:9

    Topics: Adalimumab; Adult; Aged; Anti-Inflammatory Agents; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucle

2021
New-onset autoimmune hepatitis following mRNA COVID-19 vaccination in a 36-year-old woman with primary sclerosing cholangitis - should we be more vigilant?
    Journal of hepatology, 2022, Volume: 76, Issue:1

    Topics: 2019-nCoV Vaccine mRNA-1273; Adult; Alanine Transaminase; Antibodies, Antinuclear; Aspartate Aminotr

2022